Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-028092
Filing Date
2024-12-03
Accepted
2024-12-03 16:30:12
Documents
1
Period of Report
2024-12-02

Document Format Files

Seq Description Document Type Size
1 form4-12032024_041201.html 4  
1 form4-12032024_041201.xml 4 32030
  Complete submission text file 0001415889-24-028092.txt   33547
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O UNITED THERAPEUTICS CORP 1040 SPRING STREET SILVER SPRING MD 20910
Business Address
BENKOWITZ MICHAEL (Reporting) CIK: 0001673232 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 241523200